AIP
BHVN
ARS Investment Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,892
| Closed | -$6.94M | – | 190 |
|
|
2022
Q3 | $6.94M | Buy |
45,892
+41,175
| +873% | +$6.22M | 0.95% | 31 |
|
|
2022
Q2 | $687K | Sell |
4,717
-428,407
| -99% | -$62.4M | 0.09% | 85 |
|
|
2022
Q1 | $51.4M | Sell |
433,124
-30,268
| -7% | -$3.59M | 4.95% | 2 |
|
|
2021
Q4 | $63.9M | Sell |
463,392
-3,276
| -0.7% | -$451K | 5.87% | 2 |
|
|
2021
Q3 | $64.8M | Sell |
466,668
-91,618
| -16% | -$12.7M | 6.49% | 2 |
|
|
2021
Q2 | $54.2M | Sell |
558,286
-3,156
| -0.6% | -$306K | 5.52% | 2 |
|
|
2021
Q1 | $38.4M | Buy |
561,442
+2,005
| +0.4% | +$137K | 4.46% | 2 |
|
|
2020
Q4 | $47.9M | Sell |
559,437
-137
| -0% | -$11.7K | 5.9% | 2 |
|
|
2020
Q3 | $36.4M | Sell |
559,574
-45,668
| -8% | -$2.97M | 5.72% | 3 |
|
|
2020
Q2 | $44.2M | Buy |
605,242
+2,206
| +0.4% | +$161K | 8.33% | 2 |
|
|
2020
Q1 | $20.5M | Buy |
603,036
+17,747
| +3% | +$604K | 4.95% | 4 |
|
|
2019
Q4 | $31.9M | Buy |
585,289
+14,481
| +3% | +$788K | 5.36% | 2 |
|
|
2019
Q3 | $23.8M | Buy |
570,808
+26,585
| +5% | +$1.11M | 4.28% | 2 |
|
|
2019
Q2 | $23.8M | Buy |
544,223
+80,096
| +17% | +$3.51M | 4.01% | 3 |
|
|
2019
Q1 | $23.9M | Buy |
464,127
+60,856
| +15% | +$3.13M | 4.32% | 3 |
|
|
2018
Q4 | $14.9M | Sell |
403,271
-12,284
| -3% | -$454K | 3.16% | 12 |
|
|
2018
Q3 | $15.6M | Buy |
415,555
+25,666
| +7% | +$964K | 2.42% | 16 |
|
|
2018
Q2 | $15.4M | Buy |
389,889
+129,634
| +50% | +$5.12M | 2.46% | 17 |
|
|
2018
Q1 | $6.7M | Buy |
260,255
+153,943
| +145% | +$3.97M | 0.82% | 41 |
|
|
2017
Q4 | $2.87M | Buy |
+106,312
| New | +$2.87M | 0.35% | 57 |
|